$吉利德科學(GILD.US)$Raised to Outperform From Market Perform by BMO Capital BMO Capital Upgrades Gilead Sciences to Outperform From Market Perform, Adjusts Price Target to $100 From $90. $庫倫佛寺銀行(CFR.US)$Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley Cullen/Frost Bankers Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley. $GE HealthCare Technologies(GEHC.US)$Initiated at Outperfo...
NeoGames股票討論區
NEWS
Aristocrat Leisure Completes Acquisition of Neo Group Ltd. (f/k/a NeoGames) for $29.50 per Share
NEWS
NeoGames and Aristocrat Receive Final Regulatory Approvals on Proposed Acquisition
專欄US Top Rating Updates on 5/16: GILD, NGMS, CFR, GEHC and More
BMO Capital Upgrades Gilead Sciences to Outperform From Market Perform, Adjusts Price Target to $100 From $90.
$庫倫佛寺銀行(CFR.US)$ Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley
Cullen/Frost Bankers Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley.
$GE HealthCare Technologies(GEHC.US)$ Initiated at Outperfo...
Baam
專欄Top upgrades and downgrades on 3/31
• $Baker Hughes(BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW Corp(CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $Core & Main(CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $Five Below(FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $Vector(VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...
暫無評論